Further exploration of the molecular immune functions between the IRPDGs subgroups revealed that the high-risk subgroup was more likely to involve CD8+ T cells and tumor-infiltrating lymphocytes (TILs), whereas the low-risk subgroup involved more mast cells and type II IFN responses. Here, CD8A is linked to neoplasm.